Studies have shown that consuming sesame seeds helps prevent allergies.

Published Date: 06 Mar 2023

Oral desensitization using crushed sesame seeds and tahini may be a safe and effective method to desensitize pediatric patients with sesame allergy...

Read Full News

Latest News

AI Tools Aid Lung Disease Detection in Autoimmune Diseases

AI-based deep learning models can detect interstitial lung disease from lung ultrasound images in patients with systemic sclerosis and idiopathic inflammatory myopathy.

Extended Antibiotic Use Common in Children With HS

Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a study shows.

Imaging Beats Palpation for Skin Cancer Staging

Ultrasonography and CT beat physical exam for nodal metastasis detection in patients with high-risk skin cancer but show poor sensitivity in immunosuppressed patients.

Laser Pretreatment Boosts Actinic Keratosis Clearance

Ablative fractional laser-assisted daylight photodynamic therapy can achieve higher sustained lesion-specific clearance than daylight photodynamic therapy alone in patients with actinic keratosis.

Regeneron Wins FDA Approval for First Gene Therapy for Genetic Hearing Loss

The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare genetic form of ⁠deafness, the company said on Thursday.

AI Holds Promise in Dermatology, Concerns Remain

The potential benefits and pitfalls of this rapidly evolving technology for dermatologists are debated at AAD 2026.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Todays Updates

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

Latest News

AI-based deep learning models can detect interstitial lung disease from lung ultrasound images in patients with systemic sclerosis and idiopathic inflammatory myopathy.

Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a study shows.

Ultrasonography and CT beat physical exam for nodal metastasis detection in patients with high-risk skin cancer but show poor sensitivity in immunosuppressed patients.

Ablative fractional laser-assisted daylight photodynamic therapy can achieve higher sustained lesion-specific clearance than daylight photodynamic therapy alone in patients with actinic keratosis.

The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare genetic form of ⁠deafness, the company said on Thursday.

The potential benefits and pitfalls of this rapidly evolving technology for dermatologists are debated at AAD 2026.

News All Time

FDA Approves Radiesse Filler for Decolletage Wrinkles

An agency advisory committee in 2025 recommended more study of fillers in that body area to address potential safety concerns.

Insmed Discontinues Development Of Skin Condition Drug After Mid-stage Study Miss

Insmed said on Tuesday it would discontinue the development ⁠of its treatment for a chronic, inflammatory skin condition, after ⁠the drug failed a mid-stage...

Dermocosmetics: Are Therapeutic Cosmetics Real?

From acne to rosacea, growing evidence shows targeted dermocosmetics can serve as monotherapy for mild disease or as adjunctive care, improving outcomes and treatment tolerability.

Cutaneous Appendageal Tumors: Worse Outcomes in Black People

Black patients wait weeks longer for therapy than White patients following diagnosis with rare skin cancer, and on average, deaths occur earlier.

Barriers Disrupt Isotretinoin Access in Underserved Teens

Most underserved teens report barriers to isotretinoin access, a survey found.

Adalimumab and Ixekizumab Show Similar Joint Outcomes in PsA

Adalimumab and ixekizumab show comparable effectiveness in improving joint outcomes and achieving remission in patients with psoriatic arthritis over 12 months, according to a real-world study.

Doxycycline for Acne: Impact on STIs

The lower risk for composite bacterial STI in patients taking doxycycline for acne is driven primarily by reduced risk for chlamydia, according to an analysis of TriNetX data.

India's 'Mounjaro Brides': Weight-loss Injections Become Part Of Pre-wedding Preparation

Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.

Strength Training Potentially Beneficial in Patients With HS

Development of validated interventions and guidance for physical therapists and dermatologists — and HS patients themselves — is a goal.

Indoor Tanning Linked to Melanoma Diagnosis at Younger Age

Exposure to indoor tanning, especially before age 25, is associated with substantially earlier melanoma diagnosis compared with no exposure.

Topical Probiotics Boost Diabetic Foot Ulcer Healing

Topical probiotics significantly improve healing rates and reduce time to heal in diabetic foot ulcers, compared with placebo, in a study.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Recommended News For You

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

Financial hardship common in patients with cancer

Recommended Articles For You

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms  

Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms 

The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

2.

Prostate cancer death risk is higher in late teens and early 20s weight gain.

3.

Using MRD Status to Deescalate Multiple Myeloma Therapy

4.

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

5.

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

1.

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

2.

Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention

3.

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells

4.

Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder

5.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

3.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot